ImageFIRST, the largest national linen rental and laundry service specializing in the healthcare market, announced today the launch of the Comfort Care® Maternity Gown. A portion of the proceeds from each gown rental will be donated to the National Pediatric Cancer Foundation (NPCF) to aid in their efforts to find a faster cure for pediatric cancer.
ImageFIRST is the first national linen rental provider to offer a gown specially designed with input from Mother & Baby departments across the nation to better meet the needs of expecting mothers. The Comfort Care® Maternity Gown features a lightweight, premium polyester/nylon blend fabric and front snaps to allow for skin-to-skin access and optional breastfeeding. Developed with modesty in mind, the gown also includes shoulder snaps and a full cut for extra coverage and to accommodate a variety of body types. The Maternity Gown was designed for commercial laundering and comes with a fully-managed rental and laundry program.
“In designing the Comfort Care Maternity Gown, we spoke with countless clinicians who spend their days working with women in Mother & Baby units to obtain real, honest feedback on what they are looking for in a maternity gown,” said Jim Cashman, President of ImageFIRST. “We took this input into account and the result is a modern take on the traditional garment, which better meets the needs of today’s mothers and the healthcare facilities who serve them. We are proud to offer this more comfortable solution that will significantly improve patient experience, while also making an impact on the fight against childhood cancer through our partnership with NPCF.”
Funds raised by ImageFIRST through this program will benefit the Sunshine Project, a collaborative research initiative out of the National Pediatric Cancer Foundation, a nonprofit organization dedicated to funding research to eliminate childhood cancer. By partnering with doctors and researchers from the country’s top institutions, the Sunshine Project is fast-tracking the development of new drugs and therapies that will ultimately lead to the cure of childhood cancers.
